Paroxysmal nocturnal hemoglobinuria is an uncommon blood disorder in which red blood cells become unusually vulnerable to destruction within the bloodstream. This happens because of a genetic change in bone marrow stem cells that affects protective proteins on the cell surface. Although the condition is rare, its effects can be wide-ranging, including fatigue, dark urine, shortness of breath, and a higher risk of blood clots. Because signs can vary from person to person, diagnosis may take time and usually depends on specialized blood testing.

This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.

What Is Hemoglobinuria?

Hemoglobinuria refers to the presence of hemoglobin in the urine. Hemoglobin is the protein inside red blood cells that carries oxygen throughout the body. When red blood cells break apart too quickly, hemoglobin can be released into the bloodstream and filtered by the kidneys, which may cause urine to appear dark red, brown, or cola-colored. In PNH, this can happen because red blood cells lack certain protective proteins that normally shield them from part of the immune system known as complement.

The term hemoglobinuria describes a sign rather than a disease by itself. It can appear in different medical conditions, but in PNH it often reflects ongoing destruction of red blood cells, also called hemolysis. Not everyone with this disorder will notice obvious urine discoloration every day, which is one reason the condition can be difficult to recognize early.

Hemoglobinuria Symptoms

Symptoms linked to hemoglobinuria and PNH can be subtle at first or may come and go. Many people experience fatigue because red blood cell destruction can lead to anemia, reducing the body’s ability to carry oxygen efficiently. Weakness, dizziness, headaches, rapid heartbeat, and shortness of breath are also possible. Some people notice dark urine, especially in the morning, although this pattern is not present in every case.

Other symptoms may extend beyond anemia. PNH is associated with an increased risk of blood clots, which can develop in unusual parts of the body such as abdominal veins. This may lead to abdominal pain, swelling, chest discomfort, or neurologic symptoms depending on the location. Some individuals also report difficulty swallowing, erectile dysfunction, back pain, or severe tiredness that seems out of proportion to routine anemia. Because these features overlap with many other illnesses, medical evaluation is essential.

Hemoglobinuria Causes

In PNH, the underlying cause is an acquired mutation in a gene called PIGA within bone marrow stem cells. This mutation is not usually inherited from parents. Instead, it develops during a person’s lifetime. The change prevents blood cells from making anchors needed to attach certain protective proteins to their surfaces. Without these proteins, especially CD55 and CD59, red blood cells become more exposed to complement-mediated damage.

The result is ongoing hemolysis, meaning red blood cells break down faster than the body can replace them. PNH may also occur alongside bone marrow disorders such as aplastic anemia or, less commonly, myelodysplastic syndromes. This connection helps explain why some people have low counts not only of red blood cells but also white blood cells and platelets. The disorder is complex because it involves both abnormal blood cell survival and disrupted marrow function.

How the Condition Affects the Body

The impact of PNH is not limited to dark urine or low hemoglobin. When red blood cells break apart, released hemoglobin can reduce the availability of nitric oxide, a molecule that helps blood vessels relax and supports smooth muscle function. Reduced nitric oxide may contribute to symptoms such as abdominal pain, swallowing difficulty, fatigue, and chest discomfort. Over time, repeated hemolysis can strain the kidneys and affect overall quality of life.

Blood clots are among the most serious complications. They are a major reason PNH requires careful monitoring and specialist care. Clotting risk may remain present even when typical anemia symptoms seem manageable. Some people also develop chronic kidney problems or worsening bone marrow failure. Since the condition behaves differently across patients, treatment plans are often individualized based on symptoms, lab findings, clotting history, and the extent of marrow involvement.

Diagnosis and Treatment Basics

Doctors usually diagnose PNH with flow cytometry, a blood test that can detect missing protective proteins on blood cells. Additional tests may assess anemia, kidney function, iron levels, clotting risk, and bone marrow health. Because the disorder is rare, patients are often referred to a hematologist for confirmation and long-term follow-up.

Treatment depends on disease severity and complications. Supportive care may include transfusions, iron management, folate, or treatment for related bone marrow conditions. In many cases, modern complement-inhibiting therapies are used to reduce red blood cell destruction and lower the risk of complications. Some patients may also need anticoagulation or other targeted care. Management focuses on controlling hemolysis, preventing clots, monitoring organ function, and improving day-to-day functioning rather than assuming a single course fits every person.

When Symptoms Need Prompt Attention

Certain symptoms should be taken seriously because they may point to urgent complications. Sudden chest pain, severe shortness of breath, one-sided swelling, intense abdominal pain, confusion, severe headache, or sudden weakness may suggest a blood clot or another medical emergency. Markedly reduced urine output, persistent dark urine, or signs of severe anemia such as fainting also deserve prompt assessment.

Even when symptoms seem mild, recurring fatigue, unexplained anemia, or unusual clotting events should not be ignored. PNH is rare, but it is clinically significant because delayed diagnosis can allow complications to progress. A careful history, appropriate blood testing, and specialist evaluation can help distinguish this disorder from other causes of anemia or urine discoloration.

Paroxysmal nocturnal hemoglobinuria is a rare acquired blood disorder defined by complement-sensitive blood cells, ongoing hemolysis, and a meaningful risk of clotting and bone marrow complications. Hemoglobinuria may be one visible clue, but the condition often extends far beyond urine color. Recognizing the range of symptoms, understanding the biologic cause, and knowing why specialized diagnosis matters can help place this complex disorder in clearer context for patients and families.